SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the Piper Jaffray Health Care Conference at 3:30 p.m. EST / 12:30 p.m. PST on Tuesday, November 29, 2011 in New York. During the presentation, Dr. Morrissey will provide a general business update and review the most recent publicly available data for cabozantinib, including clinical data presented at the AACR-NCI-EORTC meeting earlier this month. He will also discuss the pivotal trial plans and regulatory strategy for the compound.
